These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3491604)

  • 21. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic properties of bovine blood coagulation factors IXa alpha and IXa beta toward synthetic substrates.
    Link RP; Castellino FJ
    Biochemistry; 1983 Mar; 22(5):999-1005. PubMed ID: 6340737
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural determinants of the factor IX molecule mediating interaction with the endothelial cell binding site are distinct from those involved in phospholipid binding.
    Ryan J; Wolitzky B; Heimer E; Lambrose T; Felix A; Tam JP; Huang LH; Nawroth P; Wilner G; Kisiel W
    J Biol Chem; 1989 Dec; 264(34):20283-7. PubMed ID: 2555350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysine 5 and phenylalanine 9 of the factor IX omega-loop interact with phosphatidylserine in a membrane-mimetic environment.
    Grant MA; Baikeev RF; Gilbert GE; Rigby AC
    Biochemistry; 2004 Dec; 43(49):15367-78. PubMed ID: 15581349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity.
    Celie PH; Lenting PJ; Mertens K
    J Biol Chem; 2000 Jan; 275(1):229-34. PubMed ID: 10617609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
    Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
    J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium binding to a human factor IXa derivative lacking gamma-carboxyglutamic acid: evidence for two high-affinity sites that do not involve beta-hydroxyaspartic acid.
    Morita T; Kisiel W
    Biochem Biophys Res Commun; 1985 Jul; 130(2):841-7. PubMed ID: 3875344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
    Gilbert GE; Arena AA
    Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding of metal ions to bovine factor IX.
    Amphlett GW; Byrne R; Castellino FJ
    J Biol Chem; 1978 Oct; 253(19):6774-9. PubMed ID: 690125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.
    Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interactions of factors X and IX with phospholipid.
    Bloom JW
    Thromb Res; 1989 May; 54(4):261-8. PubMed ID: 2763266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.
    Plautz WE; Sekhar Pilli VS; Cooley BC; Chattopadhyay R; Westmark PR; Getz T; Paul D; Bergmeier W; Sheehan JP; Majumder R
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):816-828. PubMed ID: 29419409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The second epidermal growth factor-like domain of human factor IXa mediates factor IXa binding to platelets and assembly of the factor X activating complex.
    Wong MY; Gurr JA; Walsh PN
    Biochemistry; 1999 Jul; 38(28):8948-60. PubMed ID: 10413468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipids accelerate factor IX activation by surface bound factor XIa.
    Mannhalter C; Schiffman S; Deutsch E
    Br J Haematol; 1984 Feb; 56(2):261-71. PubMed ID: 6607067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activation of factors IX and X by factor VIIa].
    Komiyama Y
    Rinsho Byori; 1992 Mar; Suppl 92():73-82. PubMed ID: 1583779
    [No Abstract]   [Full Text] [Related]  

  • 39. Structural and functional characteristics of activated human factor IX after chemical modification of gamma-carboxyglutamic acid residues.
    Straight DL; Sherrill GB; Noyes CM; Trapp HG; Wright SF; Roberts HR; Hiskey RG; Griffith MJ
    J Biol Chem; 1985 Mar; 260(5):2890-3. PubMed ID: 3871774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of coagulation factors IX and X to the endothelial cell surface.
    Heimark RL; Schwartz SM
    Biochem Biophys Res Commun; 1983 Mar; 111(2):723-31. PubMed ID: 6404275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.